The medical device market has a bright future and is facing many challenges

In recent years, the country has successively issued a series of encouraging policies on domestically-made medical devices
.
Inspired by favorable policies, the domestic medical device industry has been encouraged and developed rapidly.
A large number of domestically-made innovative medical device products have gradually emerged, and many medical behaviors have also changed due to the emergence of new technologies and new products
.
It is worth mentioning that, at the same time, the performance of a large number of medical device companies has also ushered in positive results
.
Up to now, a total of more than 100 listed medical device companies in A-shares have disclosed their performance reports for the first three quarters of 2021
.
Among these companies, industry giants performed even more dazzlingly.
Among them, Mindray Medical and Intech Healthcare both gained a lot, with revenues exceeding 10 billion yuan
.
According to statistics, there are a total of 12 companies whose revenue in the first three quarters of this year exceeded 5 billion yuan
.
The industry believes that in the long run, with the deepening of domestic aging, the increase in medical and health investment, and the continuous improvement of health consumption, the prospects of the medical device industry are generally optimistic in the industry, and related companies will continue to grow in performance under this background
.
However, it should be noted that with the promising market prospects, the medical device industry is also facing many challenges that need to be resolved urgently
.
For example, the current national centralized drug procurement has reached the fifth round, and the national centralized procurement in the field of medical devices is also in the process of continuous advancement
.
In this context, the industry expects that the development of the medical device industry will be full of changes, and the mature businesses of related companies will also face growth pressure
.
It is understood that in order to cope with the growth pressure of mass procurement and other medical reform policies, as well as to break the corporate ceiling and seize the high-potential market segments, relevant medical device companies have been embarking on the fast train of development by accelerating mergers and acquisitions and license-in this year.
Tao
.
In addition to the above impacts, it should be noted that despite the rapid development of Chinese medical companies in recent years, due to their short development time and weak foundation, compared with countries with higher levels of medical device development such as the United States, Europe, and Japan, they are still There is a certain gap
.
Especially in the field of technology-intensive high-end medical equipment, it is still mainly occupied by imported medical equipment from abroad.

.
In addition, in fact, some medical devices in China still have problems such as product performance homogeneity
.
In this regard, analysts pointed out that with the accelerated development of the medical device industry and more and more challenges, the domestic medical device industry urgently needs to master more independent intellectual property rights and technological innovation for high-end medical devices
.
In addition
.
Domestic companies also need to focus deeply on the frontiers, seek unseen technologies from the source of life sciences, and allow technological innovation achievements to continue to promote the healthy development of the industry
.
At present, the industry generally believes that companies with independent R&D, innovation and development capabilities, continuous breakthroughs in new technologies and catering to new needs are expected to stand out, break the monopoly of imported companies in the field of high-end equipment, complete localized substitution and enter the international stage.
Win more room for development
.
In general, since this year, under the continuous promotion of policies, the medical device industry is accelerating its development
.
But at the same time, after the normalization of epidemic prevention and control, the medical device industry structure is also ushering in new changes.
In this context, companies in the fields of epidemic prevention medical consumables and testing should actively consider new growth points for future development
.
In addition, centralized procurement will continue to advance, and how to promote product R&D and innovation in the future and steadily gain a foothold in the market is also an urgent issue for companies to think about and solve
.